The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers. The Centers for Medicare & Medicaid Services first announced the ...
The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. The Centers for Medicare & Medicaid Services (CMS) on Tuesday announced the Better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results